Infringements of obligations laid down in connection with marketing authorisations granted in accordance with Regulation (EC) No 726/2004 which may lead to the application of a financial penalty should concern the content of a marketing authorisation and post-marketing requirements linked to a marketing authorisation, including the requirements of Community law relating to pharmacovigilance and market surveillance.
Recital 2, Commission Regulation (EC) No 658/2007 of 14 June 2007 concerning financial penalties fo…
In forcesince 14 Jun 2007